IVD & POCT Rapid Diagnostic Manufacturer
Product Detail

PPX One Step Propoxyphene Rapid Test (Oral Fluid)

Rapid lateral flow immunoassay for the qualitative detection of propoxyphene in oral fluid, used by healthcare professionals to screen for recent opioid exposure. CE Marked.

Product Description

This assay follows a competitive binding principle in a lateral flow format. A solid-phase membrane carries propoxyphene antibody and the matching drug-protein conjugate, with the antibody coupled to colloidal gold. Applied oral fluid migrates by capillary action and any propoxyphene present competes with the conjugate for limited antibody binding sites. When enough drug is present it saturates the antibody, the conjugate is not captured at the test line, and the test line disappears — a missing test line is read as positive. In a negative sample a visible test line forms. A colored control line must appear in every valid run, confirming adequate specimen and proper membrane wicking.

Propoxyphene, also known as dextropropoxyphene, is a narcotic analgesic structurally related to methadone and has been prescribed for relief of moderate pain. Its effects include respiratory depression, and it is metabolized to norpropoxyphene, which persists longer; therapeutic use as well as misuse can produce a positive result. Oral fluid testing indicates recent exposure, but interpretation should consider legitimate medication and clinical history. The test is a preliminary qualitative screen only; it does not measure concentration, timing or impairment. Presumptive positives require laboratory confirmation, and a physician should make the final diagnosis.

Specifications

Product NameCat. No.SpecimenCut-offFormat
PPX PropoxyphenePPX-R02Oral Fluid50ng/mlDevice

Send an Inquiry

Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the PPX One Step Propoxyphene Rapid Test (Oral Fluid).